Inner Mongolia Furui Medical Science Co., Ltd.
Shenzhen Stock Exchange 300049.SZ
Inner Mongolia Furui Medical Science Co., Ltd. Net Income Margin for the year ending December 31, 2023: 8.80%
Inner Mongolia Furui Medical Science Co., Ltd. Net Income Margin is 8.80% for the year ending December 31, 2023, a -9.28% change year over year. Net Income Ratio, also known as the profit margin, is the ratio of net income to net sales, showing the percentage of revenue that remains as profit after all expenses are deducted.
-
Inner Mongolia Furui Medical Science Co., Ltd. Net Income Margin for the year ending December 31, 2022 was 9.70%, a -8.67% change year over year.
-
Inner Mongolia Furui Medical Science Co., Ltd. Net Income Margin for the year ending December 31, 2021 was 10.63%, a 38.61% change year over year.
-
Inner Mongolia Furui Medical Science Co., Ltd. Net Income Margin for the year ending December 31, 2020 was 7.67%, a 46.96% change year over year.
-
Inner Mongolia Furui Medical Science Co., Ltd. Net Income Margin for the year ending December 31, 2019 was 5.22%, a 27.70% change year over year.
Key data
| Date | Net Income Margin | EBITDA Margin | EBIT Margin | EBITDA |
|---|
Market news
Loading...
Don’t Miss A Beat
Shenzhen Stock Exchange: 300049.SZ
| CEO | Mr. Guanyi Wang |
| IPO Date | Jan. 20, 2010 |
| Location | China |
| Headquarters | Caesar Center |
| Employees | 703 |
| Sector | Healthcare |
| Industries | |
Description
Inner Mongolia Furui Medical Science Co., Ltd. operates as a professional medical service platform company. The company provides disease diagnosis, drug treatment, and chronic disease management products in the liver disease field. It also offers health management center and medical care services. The company was formerly known as Inner Mongolia FuRui Pharmaceutical Limited Liability Company. Inner Mongolia Furui Medical Science Co., Ltd. was founded in 1998 and is headquartered in Beijing, China.
Key trends
Past 5 years
StockViz Staff
February 3, 2025
Any question? Send us an email